# MOUNJARO
> **NDA215866** · New Drug Application · Sponsor: ELI LILLY AND CO · Approved 2022-05-13
## Drug
- **FDA Application Number:** NDA215866
- **Application type:** New Drug Application
- **Brand name:** MOUNJARO
- **Generic name:** TIRZEPATIDE
- **Active ingredients:** TIRZEPATIDE
- **Dosage form:** SOLUTION
- **Route:** SUBCUTANEOUS
- **Marketing status:** Prescription
- **Sponsor:** ELI LILLY AND CO
- **Manufacturer:** Eli Lilly and Company
- **First approval:** 2022-05-13
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215866)
---
*AI Analytics · CC0 1.0*